Lecture 9: Functional and Qualitative Disorders of Platelets
Michele P. Lambert MD
Presentation Date:
October 29, 2026
Speaker Disclosures
Disclosures for Michele P. Lambert MD
> Advisory board member for Octapharma, Dova, Principia, Argenx, Sanofi, Janssen and Shionogi
> Consultant for Novartis, Shionogi, Dova, Principia, Argenx, Rigel, Janssen, Sobi, and Bayer
Research funding from Sysmex, Novartis, Rigel, Principia, Argenx, Dova, Octapharma, Janssen, Sobi and Astra Zeneca
> Coag Lab Research Funds from Rocket Pharmaceuticals and Werfen
> Medical Advisory Board Member for PDSA, CdLS foundation, 22q Society FWG+BD
> Co-Chair of Hemostasis/Thrombosis GCEP and member Platelet Disorder VCEP for ClinGen
> Coagulation Laboratory Research Funding: Rocket Pharmaceuticals; Werfen
Learning Objectives
1. Identify the common clinical presentations of qualitative platelet disorders (platelet function disorders: PFD)
2. Understand the clinical manifestations of PFD and the impact on patients and families
3. Describe the limitations of currently available clinical testing
4. Demonstrate the potential impact of novel therapeutics on patients with inherited platelet disorders
5. List potential acquired causes of platelet dysfunction
.jpg)
